losartan and endomorphin 2

losartan has been researched along with endomorphin 2 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, HH; Cheng, PW; Ho, CY; Ho, WY; Sun, GC; Tseng, CJ; Wong, TY; Yeh, TC	1

Other Studies

1 other study(ies) available for losartan and endomorphin 2

Article	Year
Angiotensin II inhibits DDAH1-nNOS signaling via AT1R and μOR dimerization to modulate blood pressure control in the central nervous system. Clinical science (London, England : 1979), 2019, 12-12, Volume: 133, Issue:23 Topics: Amidohydrolases; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Dimerization; Extracellular Signal-Regulated MAP Kinases; Hypertension; Losartan; Male; Nitric Oxide; Nitric Oxide Synthase Type I; Oligopeptides; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptors, Opioid, mu; Signal Transduction; Solitary Nucleus	2019

Article

Year

Angiotensin II inhibits DDAH1-nNOS signaling via AT1R and μOR dimerization to modulate blood pressure control in the central nervous system.

Clinical science (London, England : 1979), 2019, 12-12, Volume: 133, Issue:23

Topics: Amidohydrolases; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Dimerization; Extracellular Signal-Regulated MAP Kinases; Hypertension; Losartan; Male; Nitric Oxide; Nitric Oxide Synthase Type I; Oligopeptides; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptors, Opioid, mu; Signal Transduction; Solitary Nucleus

2019